Blogs & News Articles

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) has said Propagation Services Canada Inc (PSC), its flagship cultivation asset located in Delta, British Columbia, is continuing its momentum towards first commercial sales and is expected to report initial revenues in the summer of 2021.

The cannabis firm noted that the first commercial crop for sale will include three proprietary strains - Mimosa 37, Kosher Kush, and Gelato - which it said have been selected for their strong demand in Canada’s dried flower market, as well as their growing attributes within the greenhouse environment which align with their low-cost high-THC cannabis attributes.

READ: AgraFlora Organics expects to enter Canadian edibles market in 1Q 2021

AgraFlora added that PSC has gathered valuable data from crops grown to date and continues to “develop and strategize to further aid in its positioning as a leader in low-cost product”.

The firm also said recent modifications and calibrations provided by an international partner to existing drying rooms have allowed PSC to almost double anticipated drying capacity for a minimal investment, and that PSC will be optimizing its propagation operations by fine-tuning its climate strategy to produce healthy, rooted cuttings more quickly with high success rate monitoring irrigation mixtures to produce custom nutrient formulations for each stage of plant growth.

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) said Wednesday it expects to enter the Canadian edibles market in the first quarter of 2021. 

In a statement, the company said it has completed the first phase of research and development trials at its Health Canada-licensed, 51,000 square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba. 

Prior to receiving a standard processing license from Health Canada, the company had commenced cultivating long-term production relationships through R&D trials utilizing the company’s Health Canada R&D license. 

READ: AgraFlora Organics receives cannabis edibles processing licence for its Winnipeg manufacturing facility

And now that the development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and products, AgraFlora said it is nearly prepared to enter the edibles market soon.  

AgraFlora Organics International Inc () (OTCPINK:AGFAF) (FRA:PU31) announced that on December 11, 2020, it received a newly-issued standard processing license from Health Canada for the company’s 51,000-square-foot, fully-automated cannabis edibles manufacturing facility in Winnipeg, Manitoba.

The facility is part of the Edibles and Infusions Corporation (EIC) joint venture formed between AgraFlora and one of North America’s leading confectionary manufacturing families.

“We are delighted to receive the Manufacturing License at our Edibles Facility within our outlined timeframe. Our strong evidence package submission is a testament to the hard-working team we have assembled. We are now able to commercialize our formulations and bring to market cannabis activated pectin and gelatin gummies, hard candy, and sugar-free variants,” EIC co-founder and operational manager James Fletcher said in a statement.

READ: AgraFlora Organics intends to be a top cannabis player in Canada and Europe 

The Winnipeg manufacturing facility, when fully operational, expects to produce more than 250,000 pieces of precisely-dosed edibles per eight-hour shift.   

AgraFlora Organics International Inc () (OTCPINK:AGFAF) (FRA:PU31) reported that it expects to roll out the first cannabis sales in mid 2Q 2021 from cultivation operations at the Propagation Services Canada (PSC) facility in Delta, British Columbia.  

The company said based on the data collected from its 4Q 2020 harvest, it expects to cultivate 10,000 plants and aims to yield 50 grams per plant of saleable product in 2021.

“Our data shows that timing is right in the market for our product. Currently >20% THC cannabis flower varieties rising in value and we aim to solidify good partners for our product and also take advantage of the robust spot market,” AgraFlora Board of Directors said in a statement.

READ: AgraFlora Organics intends to be a top cannabis player in Canada and Europe 

AgraFlora added that the grow team at the Delta Facility believes that their multi-generational experience and favourable growing environment will boost PSC to become a leader in pricing low cost, high-THC cannabis.

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) has acquired High Performance Liquid Chromatography (HPLC) equipment for its 51,000-square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba.

The company said the addition of an Agilent HPLC driven analytical testing platform at the edibles facility will allow it to rapidly develop and launch new edibles products which have already been formulated.

"Implementing this suite of HPLC analytical equipment into our production strategy will reduce our 3rd party product testing costs, while improving product safety and quality by allowing us to continuously monitor edible production to ensure quality standards are being met,” said James Fletcher, co-founder and operational manager for Edibles and Infusions Corporation, a subsidiary that runs the plant, in a statement.

READ: Agraflora Organics responds to Health Canada's RMI regarding its standard processing license application for edibles facility

“This should also greatly improve our speed to market with unique SKU’s and allow us to offer some of the most price competitive products in the market,” Fletcher added.

() (FRA:PU31) (OTCPINK:AGFAF) said that Propagation Services Canada Inc. (PSC), its flagship cultivation asset located in Delta, British Columbia has received an agriculture loan to bring its cannabis cultivation to market and continue Phase 1 of the company’s cultivation strategy.

As part of the loan, the group's Delta Facility will receive $5,000,000 which will provide full funding to the licensed cultivation areas and will allow the PSC team to bring their first crop of low cost, high potency cannabis to market, on a wholesale basis, in Q1 2021.

READ: Agraflora Organics responds to Health Canada's RMI regarding its standard processing license application for edibles facility in Winnipeg

The curated portfolio of elite genetics at the Delta facility has been tailored to work with PSC's Delta-based infrastructure and utilizing 422,828 square foot of cultivation space with state-of-the-art semi-pressurized, semi-open Venlo greenhouses.

In a statement, the AgraFlora board of directors commented: “Having a fully-funded Phase 1 cultivation strategy allows us to deliver high potency cannabis strains in 2021. As partners at PSC, we have full confidence in the Houwelings family's ability to achieve this strategy, given their long history of high-quality agricultural production in low-cost environments, as well as the healthy condition of our award-winning genetics.”

Agraflora Organics International Inc () (OCTMKTS:AGFAF) has submitted a formal response to Health Canada's first request for more information (RMI) regarding the standard processing licence application for Agraflora's 51,000-square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba. 

In a statement Friday, the company said the RMI response is a key step towards achieving the standard processing license for the edibles facility. Agraflora in May submitted its site evidence package to Health Canada for the manufacturing license.

AgraFlora noted that on August 27 it launched research and development trials through its Health Canada R&D license to dial in formulations for cannabis-activated pectin and gelatin gummies, hard candy, and sugar-free variants. 

READ: AgraFlora says subsidiary Farmako in distribution agreement with Adjupharm to supply medical cannabis in Germany

The Vancouver-based company said it is currently in discussions with multiple Canadian cannabis companies with respect to product development and formulation as an R&D service. It believes that R&D services contracts are a critical path to long-term production relationships.

AgraFlora Organics International Inc () said its subsidiary Farmako GmbH has entered into a binding distribution agreement with Adjupharm GmbH to supply medical cannabis in Germany. 

Adjupharm, the German subsidiary of (), will provide EU Good Manufacturing Practice (GMP) quality medical cannabis to Farmako for a three-year term, according to a statement.

Farmako will distribute the products in Germany to patients under the brand to its established network of German pharmacies. The first products are expected to launch in October 2020.

READ: AgraFlora says Farmako subsidiary secures added supply of EU-GMP certified medical cannabis from ZenPharm

The products provided by Adjupharm and distributed by Farmako include initially high potency THC flower. The portfolio is expected to be enhanced throughout the first quarter of 2021 by balanced THC and CBD flower as well as CBD dominant flower.

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) said on Tuesday that its subsidiary Farmako GmbH has executed a binding supply agreement with ZenPharm Limited, a subsidiary of Global Inc (), to secure additional medical cannabis stock.

As result of the supply agreement, ZenPharm will supply EU Good Manufacturing Practice (GMP) quality medical cannabis flower cultivated by to Farmako for distribution to medical cannabis patients in Germany. The agreement will facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany over a three-year term, said the company.

Farmako will distribute the products to its established network of German pharmacies and the products will carry Farmako’s branding, a key step in building “brand awareness and loyalty” with physicians, pharmacists and patients, noted the company. The products initially include high potency THC flower and balanced THC and CBD flower, two product categories that management believes are in highest demand in Germany. Shipments to Farmako are expected to start in November 2020.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

Asterion Cannabis Inc said Thursday its research partner had received sativa seeds for a tissue culture program designed to enable high volume and pathogen-resistant plant cultivation for medicinal purposes.

The Vancouver-based company said the seeds were received by the University of Queensland’s Queensland Alliance for Agriculture and Food Innovation (QAAFI) last week.

QAAFI has begun the program, which is aiming to expedite clonal propagation of elite sections of marijuana plants to allow for high-volume and uniform plant cultivation. Clonal propagation is the multiplication of genetically identical copies of individual plants.

READ: Asterion Cannabis updates on milestones in bid to become world’s largest pharma-grade medicinal cannabis supplier

In a statement, Asterion CEO Steven Van Deventer told shareholders that the firm was pleased that all the required regulatory approvals were received and the seeds are now in QAAFI’s possession. 

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) said it has received a necessary CRA tax license and is now creating test cannabis edibles products through its Health Canada licensed research & development (R&D) lab at the group’s edibles manufacturing facility in Winnipeg, Manitoba.

The company said through its R&D license it has now dialed in formulations for cannabis activated pectin and gelatin gummies, hard candy and sugar-free variants.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

"As part of the R&D program, we have begun a testing project with Agilent to improve testing standards, methods, and ensure consistent quality. Our efficient and highly automated R&D production allows us to provide a variety of sample products for our prospective clients to try for their established brands,” said James Fletcher, one of the founders and the operational manager of Edibles and Infusions Corporation, a joint venture formed between AgraFlora and one of North America’s leading confectionery manufacturing families.

AgraFlora also said it submitted its site evidence package to Health Canada for a processing license on May 28, adding that it is in regular contact with the body and remains committed to the timeline of receiving the license in the fourth quarter of 2020.

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) has provided an update on progress at its flagship cultivation asset in Delta, British Columbia which embarked on planting using a curated portfolio of live-plant genetics in June this year.

Vancouver-based AgraFlora said the Delta facility expects to see its first harvest early in the fourth quarter of this year, with the first product available for sale of “low-cost, high potency cannabis strains” in the first quarter of 2021 on a wholesale basis. The company is in a joint venture with Propagation Services Canada Inc, which operates the 2.2 million-square-foot greenhouse complex in Delta, British Columbia.

AgraFlora said the "elite genetics" at the Delta facility has been tweaked to work with Propagation Services Canada's cultivation program and is expected to yield up to 44 varieties of strains to offer to its wholesale clients a “robust product offering,” while maintaining “strong cannabinoid and terpene content” plant yield every year.

READ: AgraFlora Organics International to exchange $3 million of debentures for shares

Cannabis One Holdings Inc () (OTCMKTS:CAAOF) announced Tuesday the appointment of Alnoor Nathoo to its board of directors, one of several new additions the company said it plans to make. 

The company also announced two resignations, that of board director Bernard Radochonski and interim CFO Theresa Mohan. Radochonski still remains a large shareholder and long-standing supporter of the company, the group noted.

The executive-level personnel changes come as Cannabis One prepares to strategically rebrand itself INDVR Brands Inc in a bid to better reflect its cannabis distribution business model.

READ: Cannabis One to transform into fully licensed Colorado operator as it cuts deal to acquire Cannabis Corp

In a statement, Cannabis One noted that Nathoo brings a wealth of public and private company experience. He is the principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada. 

Cannabis One Holdings Inc () (OTCMKTS:CAAOF) has announced plans to change its name to INDVR Brands Inc in a bid to better reflect its cannabis distribution business model.

The Vancouver-based company is advancing a “House of Brands” model that aggregates and optimizes popular cannabis names in North America. It also owns a retail storefront in Colorado called The Joint, which was ranked the number one dispensary in the state by Leafly for three consecutive years.

The company also announced that CEO Jeffrey Mascio has resigned from the Cannabis One leadership team as well as the board of directors effective immediately. Mascio will remain involved with the company in an executive advisory role and the company's president Joshua Mann will take up the interim CEO position.

In a statement on Friday, Mann said that directors and executive management team have collectively decided that its current name does not properly reflect its business or its business model. The name change will not affect the firm’s existing share structure or shareholder rights, the group said.